Warning! GuruFocus detected
1 Severe warning sign
with KVUE.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Kenvue Inc
NAICS : 811490
SIC : 2842
ISIN : US49177J1025
Compare
Compare
Traded in other countries / regions
KVUE.USAJ4D.GermanyKVUE.Mexico Index Membership
S&P 500Russell 1000Russell 3000 IPO Date
2023-05-04Description
Kenvue is the world's largest pure-play consumer health company by sales, generating $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.12 | |||||
| Equity-to-Asset | 0.38 | |||||
| Debt-to-Equity | 0.9 | |||||
| Debt-to-EBITDA | 3.53 | |||||
| Interest Coverage | 6.11 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 2.43 | |||||
| Beneish M-Score | -2.5 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 0.3 | |||||
| 3-Year EBITDA Growth Rate | -12.8 | |||||
| 3-Year EPS without NRI Growth Rate | -2 | |||||
| 3-Year FCF Growth Rate | 220.9 | |||||
| 3-Year Book Growth Rate | -22.4 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 5.41 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 2.63 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 16.9 | |||||
| 9-Day RSI | 29.92 | |||||
| 14-Day RSI | 38.65 | |||||
| 3-1 Month Momentum % | 10.47 | |||||
| 6-1 Month Momentum % | 5.69 | |||||
| 12-1 Month Momentum % | 16.11 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.96 | |||||
| Quick Ratio | 0.69 | |||||
| Cash Ratio | 0.19 | |||||
| Days Inventory | 101.08 | |||||
| Days Sales Outstanding | 52.11 | |||||
| Days Payable | 135.48 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.65 | |||||
| Dividend Payout Ratio | 0.71 | |||||
| Forward Dividend Yield % | 3.67 | |||||
| 5-Year Yield-on-Cost % | 3.65 | |||||
| 3-Year Average Share Buyback Ratio | -0.4 | |||||
| Shareholder Yield % | 3.22 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 57.97 | |||||
| Operating Margin % | 17.05 | |||||
| Net Margin % | 6.67 | |||||
| FCF Margin % | 8.64 | |||||
| ROE % | 9.84 | |||||
| ROA % | 3.84 | |||||
| ROIC % | 8.49 | |||||
| 3-Year ROIIC % | 16.13 | |||||
| ROC (Joel Greenblatt) % | 93.78 | |||||
| ROCE % | 8.8 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 42.13 | |||||
| Forward PE Ratio | 19.49 | |||||
| PE Ratio without NRI | 19.59 | |||||
| PS Ratio | 2.78 | |||||
| PB Ratio | 4.42 | |||||
| Price-to-Free-Cash-Flow | 32.18 | |||||
| Price-to-Operating-Cash-Flow | 24.32 | |||||
| EV-to-EBIT | 27.26 | |||||
| EV-to-Forward-EBIT | 15.26 | |||||
| EV-to-EBITDA | 20.39 | |||||
| EV-to-Forward-EBITDA | 15.17 | |||||
| EV-to-Revenue | 3.26 | |||||
| EV-to-Forward-Revenue | 3.25 | |||||
| EV-to-FCF | 37.7 | |||||
| Earnings Yield (Greenblatt) % | 3.67 | |||||
| FCF Yield % | 3.13 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:KVUE
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Kenvue Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 15,455 | ||
| EPS (TTM) ($) | 0.53 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 31.3 | ||
| 14-Day RSI | 38.65 | ||
| 14-Day ATR ($) | 0.595803 | ||
| 20-Day SMA ($) | 23.41 | ||
| 12-1 Month Momentum % | 16.11 | ||
| 52-Week Range ($) | 17.67 - 24.46 | ||
| Shares Outstanding (Mil) | 1,911.24 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Kenvue Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Kenvue Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Kenvue Inc Frequently Asked Questions
What is Kenvue Inc(KVUE)'s stock price today?
The current price of KVUE is $22.33. The 52 week high of KVUE is $24.46 and 52 week low is $17.67.
When is next earnings date of Kenvue Inc(KVUE)?
The next earnings date of Kenvue Inc(KVUE) is 2025-05-07 Est..
Does Kenvue Inc(KVUE) pay dividends? If so, how much?
The Dividend Yield %  of Kenvue Inc(KVUE) is 3.65% (As of Today), Highest Dividend Payout Ratio of Kenvue Inc(KVUE) was 0.71. The lowest was 0.31. And the median was 0.51. The  Forward Dividend Yield % of Kenvue Inc(KVUE) is 3.67%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers